Diketopiperazines (cyclic dipeptide) produced by probiotic bacteria.
To avoid side effects of conventional antibiotics and disinfectants used for prevention of oral diseases such as dental caries, periodontitis, and oral candidiasis, application of probiotics has attracted attention recently. However, difficulties arise when applying those probiotics in the oral cavity, because exogenous probiotic bacteria do not colonize easily in the established oral microbiota. Even, if we are able to overcome the restriction of colonization by probiotic bacteria in the oral cavity, it comes with the risk of dental caries due to the potential acidic environment generated by probiotic bacteria. To solve these problems, “biogenics,” bacterial cell-free probiotics using only the effective substances metabolically produced by probiotic bacteria, is recommended for application in the oral cavity. The concept and frontline of biogenic research will be introduced and discussed.
- oral diseases
- dental caries
More than 700 bacterial species live in the oral cavity [1, 2]. These bacteria form their own indigenous flora in their habitats, such as teeth, gingival sulcus, and tongue dorsum, making the oral environment considerably complicated. Oral indigenous bacteria coexist with humans and are vital for preventing colonization by foreign pathogenic microorganisms in the oral cavity. Such oral indigenous bacteria proliferate with time, and together with the extracellular polymeric substance (EPS) that they produce, form a biofilm visible even to the naked eye known as dental plaque [3, 4, 5].
It has recently been clarified that the formation of biofilms is controlled by quorum-sensing (QS) signals in a communication system between microorganisms that sense each other’s abundance [6, 7, 8]. It has further been shown that microorganisms constituting a biofilm activate the expression of pathogenic factors when QS signaling molecules, so-called “autoinducers (AI),” act as transcription factors .
2. The potential pathogenicity of dental plaque as oral biofilm
Oral plaque contains also dental caries and periodontal disease causing organisms [9, 10, 11, 12], and when these exert their potential pathogenicity, they are considered to accelerate biofilm formation even more. Generally it can be said that with increasing thickness of the biofilm, the bacterial metabolites build up at the bottom of the biofilm, and the caries and periodontitis occurrence proliferate.
Caries and periodontal diseases are called the two major dental diseases, and both of them occur as oral infectious diseases which are caused by specific bacteria known as cariogenic bacteria (such as
3. Oral application of probiotics and problems
The method of preventing caries and periodontal disease is basically the mechanical removal of the entire plaque by brushing, etc. However in the case of onset of the disease, antimicrobial drugs are administered for the treatment of the acute phase of periodontal disease, and antifungal administration is the first choice for treatment of oral candidiasis. However, the use of antimicrobial agents has shown problems regarding adverse effects such as drug-resistant bacteria and allergies, indicating the limitation of chemotherapy . Therefore, attention has recently focused on probiotic bacteria such as bifidobacteria and lactobacilli recognizing the usefulness for improving dysbiosis . Although probiotics were originally intended to improve dysbiosis of the intestinal flora , their usefulness is also assumed in the dental field. Attempts have been made for direct use in the oral cavity to prevent diseases such as caries and periodontal disease, and several results have been reported [16, 17, 18]. Ishikawa
However, in these reports, there are few basic facts on the effects of probiotics on the oral flora and the antibacterial substances produced by them, so progress and establishment of practical applications based on the underlying mechanism has not been accomplished. In addition, genera
As another fundamental issue, previous studies have highlighted the limitation of colonization and fixation of nonnatural probiotic bacteria in the intestinal tract [20, 21]. This phenomenon of transiency, but not permanency in colonization, is also relevant for probiotic applications in the oral cavity [16, 22, 23]. Even if we are able to address the restriction of colonization of probiotic bacteria in the oral cavity, it comes with the risk of dental caries due to the potential acidic environment generated by probiotic bacteria.
4. The concept of biogenics
To overcome the above problems, “biogenics” as a new idea has been introduced. Biogenics is a kind of functional food, using only the ingredients, which have a positive effect on the host with regard to immunostimulating or immunosuppressing mutagenesis, tumorigenesis, peroxidation, hypercholesterolemia, or intestinal putrefaction . Achieving a probiotic effect by the intake of nonviable probiotic bacteria has been proposed in previous reports. For example, the life span of mice increased, when they were fed with pasteurized fermented milk [25, 26]. A significant reduction of the Ehrlich ascites tumor growth in mice was also reported . In addition, it was shown that heat-inactivated
5. Antibacterial substances produced by lactic acid bacteria
Research of probiotics for intestinal health has revealed several antibacterial substances produced by lactic acid bacteria in addition to organic acids such as lactic and acetic acids . These are (1) hydrogen peroxide , (2) bacteriocins , and (3) low-molecular-weight antimicrobial substances.
5.1 Hydrogen peroxide (H2O2)
Hydrogen peroxide is produced by most
Lactic acid bacteria produce bacteriocins, proteinaceous antimicrobial substances with molecular weights of several thousand daltons or more. Bacteriocins can be divided into five classes according to their primary structure, molecular composition, and physical and functional properties [43, 44]. However, bacteriocins produced by lactic acid bacteria against
5.3 Low-molecular-weight antimicrobial substances
Reuterin, an antibacterial substance (also known as 3-hydroxypropionaldehyde; molecular weight, 74 Da; composition formula, C3H6O2), is a product of glycerol fermentation, which has been seen in several probiotic bacteria. These probiotic bacteria include not only
As the smallest peptides, diketopiperazines (DKPs, cyclic dipeptides) are known to possess several physiological activities, including an antimicrobial effect.
diketopiperazines are a group of cyclic organic compounds where two amino acids are connected by a peptide bond, forming a lactam, and it is the first peptide whose three-dimensional structure has been completely solved by Robert Corey in the 1930s . Corey determined the structure of the cyclic anhydride of the dipeptide glycylglycine. Diketopiperazines are also biosynthesized from amino acids in diverse organisms including mammals and are considered to be secondary metabolites . Although some protease enzymes, such as dipeptidyl peptidase, produce a dipeptide by cleavage from the protein terminus, it is known that the resulting dipeptide cyclizes spontaneously to form a diketopiperazine. In addition, diketopiperazines are attractive scaffolds for drug design due to their structural properties such as a rigid structure, optical activity, and various side-chain structures . Both natural diketopiperazines and synthetic diketopiperazines have been reported to possess various physiological activities including antitumor activity , antiviral activity , antibacterial activity , and antimicrobial activity . However, there are only few reports on DKP produced by probiotic bacteria (Table 1). In addition, the antimicrobial mechanism is also poorly understood.
|Cyclic dipeptide||Origin||Biological function||References|
6. Anti-inflammatory substances produced by lactic acid bacteria
Periodontitis and candidiasis are both inflammatory diseases; therefore, inflammation symptoms are desired to be cured by biogenics, but there are few candidates for that.
CLA is a general term for regioisomers and structural isomers of linoleic acid having a conjugated diene structure.
Diene structure means there are two double bonds with a single bond in between. Rumenic acid, for example, is one of the 28 isomers of CLAs and exists in the fat and dairy products of ruminants . It is a trans fat; however, CLAs can also appear as cis-fats. CLAs are known to reduce the production level of IgE and a chemical mediator leukotriene in a rat inflammatory model . However, the opposite effect of increasing serum C-reactive protein value and reducing serum adiponectin level in human by CLA supplementation was observed recently .
7. Understanding the property of biofilm
Most bacteria and fungi have the potential to grow in a biofilm, in an environment with liquid flow and solid surfaces. Biofilm formation, which has been experimentally observed in single bacteria, is now known not only to cross species but also to cross the kingdom of microbes. In human bodies, such situations particularly exist in the resident microbiota. Microorganisms including oral pathogens have the potential to express pathogenic properties in biofilms, contrary to the planktonic type. In other words, the so-called biofilm phenotypes upregulate the production of EPS that block the stimuli or stress from outside the biofilm, such as antibiotics and disinfectants. The EPS also provides sticky intercellular binding material and extracellular energy storage compounds [74, 75] to promote interaction among contacting microbial cells , resulting in complex and dynamic interplay.
8. Disruption of the quorum-sensing signals
Recently, a QS inhibitor (QSI) and QS signal quencher (QQ) molecule attracted attention in regard to understanding biofilm infections. Biofilm formation is triggered and controlled by a cell-to-cell communication process in harmony with the bacterial population density known as quorum-sensing system, which is based on small molecules termed autoinducers . Some reports revealed that bacteriocins produced by probiotic lactobacilli such as
Biogenics is based on the concept of using the active ingredients which were revealed by the mechanism of oral probiotics. Biogenics is expected to be a prevention method for oral diseases that can be implemented without the problems associated with the use of probiotic bacteria, namely the involvement of acids harmful to teeth. The emergence of resistant bacteria against naturally occurring substances of biogenic candidates is not yet known. Furthermore, it is possible to combine substances which contribute to the health of the oral cavity, with those contributing to systemic health, such as control substances for blood sugar level, blood pressure, neutral fat, antioxidants, anti-stress, immune enhancement, anti-inflammation, antianxiety, and antidepressants. Therefore, the progress of practical application is expected. However, the elucidation of the mechanism of action is still in the beginning, and further study is needed.
A part of this study was supported by JSPS KAKENHI Grant Number JP18K17057 and MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2015–2019.
Conflict of interest
There are no conflicts of interest.
Paster BJ, Olsen I, Aas JA, Dewhirst FE. The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontology 2000. 2006; 42(1):80-87
Marsh PD, Devine DA. How is the development of dental biofilms influenced by the host? Journal of Clinical Periodontology. 2011; 38:28-35
Sutherland IW. Biofilm exopolysaccharides: A strong and sticky framework. Microbiology. 2001; 147:3-9
Bales PM. Purification and characterization of biofilm-associated EPS exopolysaccharides from ESKAPE organisms and other pathogens. PLoS One. 2013; 8(6):e67950
Koo H. The exopolysaccharide matrix: A virulence determinant of cariogenic biofilm. Journal of Dental Research. 2013; 92(12):1065-1073
Melissa B. Quorum sensing in bacteria. Annual Review of Microbiology. 2001; 55:165-199
de Kievit TR et al. Quorum sensing in Pseudomonas aeruginosabiofilms. Environmental Microbiology. 2001; 11(2):279-288
Li YH, Tian X. Quorum sensing and bacterial social interactions in biofilms. Sensors (Basel). 2012; 12(3):2519-2538
Marsh PD, Bradshaw DJ. Dental plaque as a biofilm. Journal of Industrial Microbiology. 1995; 15(3):169-175
Stralfors A. Studies of the microbiology of caries; the buffer capacity of the dental plaques. Journal of Dental Research. 1948; 27(5):587-592
Poole DF, Newman HN. Dental plaque and oral health. Nature. 1971; 234(5328):329-331
Axelsson P, Lindhe J. The effect of a plaque control program on gingivitis and dental caries in schoolchildren. Journal of Dental Research. 1971; 56(C):142-148
Watanabe T. Infectious drug resistance in enteric bacteria. The New England Journal of Medicine. 1966; 275:888-894
Gupta G. Probiotics and periodontal health. Journal of Medicine and Life. 2011; 4:387-394
Fuller R. Probiotics in man and animals. The Journal of Applied Bacteriology. 1989; 66:365-378
Krasse P, Carlsson B, Dahl C, Paulsson A, Nilsson A, Sinkiewicz G. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swedish Dental Journal. 2006; 30:55-60
Vivekananda MR, Vandana KL, Bhat KG. Effect of the probiotic Lactobacilli reuteri(Prodentis) in the management of periodontal disease: A preliminary randomized clinical trial. Journal of Oral Microbiology. 2010; 2:2. DOI: 10.3402/jom.v2i0.5344
Riccia DN, Bizzini F, Perilli MG, Polimeni A, Trinchieri V, Amicosante G, et al. Anti-inflammatory effects of Lactobacillus brevis(CD2) on periodontal disease. Oral Diseases. 2007; 13:376-385
Ishikawa H, Aiba Y, Nakanishi M, Oh-Hashi Y, Koga Y. Suppression of periodontal pathogenic bacteria by the administration of Lactobacillus salivariusTI2711. Journal of the Japanese Society of Periodontology. 2003; 45:105-112
Haenel H. Aspekte der mikroökologischen beziehungen des makroorganismus. Mikroorganismen im menschlichen und tierischen darm und in anderen organen. Zentralblatt für Bakteriologie. 1960; 176:305-426
Mitsuoka T, Kaneuchi C. Ecology of the bifidobacteria. The American Journal of Clinical Nutrition. 1977; 30:1799-1810
Meurman JH, Antila H, Salminen S. Recovery of Lactobacillusstrain GG (ATCC 53103) from saliva of healthy volunteers after consumption of yoghurt prepared with the bacterium. Microbial Ecology in Health and Disease. 1994; 7(6):295-298
Caglar E, Topcuoglu N, Cildir SK, Sandalli N, Kulekci G. Oral colonization by Lactobacillus reuteriATCC 55730 after exposure to probiotics. International Journal of Paediatric Dentistry. 2009; 19(5):377-381
Mitsuoka T. Significance of dietary modulation of intestinal flora and intestinal environment. Bioscience and Microflora. 2000; 19(1):15-25
Arai K, Murota I, Hayakawa K, Kataoka M, Mitsuoka T. Effects of administration of pasteurized fermented milk to mice on the life-span and intestinal flora. Journal of Japan Society of Nutrition and Food Sciences. 1980; 33:219-223 [Japanese]
Takano T, Arai K, Murota I, Hayakawa K, Mizutani T, Mitsuoka T. Effects of feeding sour milk on longevity and tumorigenesis in mice and rats. Bifidobacteria and Microflora. 1985; 4(1):31-37
Terada A, Bukawa W, Kan T, Mitsuoka T. Effects of the consumption of heat-killed enterococcus faecalis EC-12 preparation on microbiota and metabolic activity of the faeces in healthy adults. Microbial Ecology in Health and Diseases. 2004; 16:188-194
Sawada D, Sugawara T, Ishida Y, Aihara K, Aoki Y, Takehara I, et al. Effect of continuous ingestion of a beverage prepared with Lactobacillus gasseriCP2305 inactivated by heat treatment on the regulation of intestinal function. Food Research International. 2016; 79:33-39
Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. Journal of Dairy Science. 1995; 78:777-783
Ross RP, Mills S, Hill C, Fitzgerald GF, Stanton C. Specific metabolite production by gut microbiota as a basis for probiotic function. International Dairy Journal. 2010; 20:269-276
O'Shea EF, Cotter PD, Stanton C, Ross RP, Hill C. Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: Bacteriocins and conjugated linoleic acid. International Journal of Food Microbiology. 2012; 152:189-205
Hayes M, Coakley M, O'sullivan L, Stanton C. Cheese as a delivery vehicle for probiotics and biogenic substances. Australian Journal of Dairy Technology. 2006; 61:132
Möller NP, Scholz-Ahrens KE, Roos N, Schrezenmeir J. Bioactive peptides and proteins from foods: Indication for health effects. European Journal of Nutrition. 2008; 47:171-182
Bogsan CS, Florence ACR, Perina N, Hirota C, Soares FASM, Silva RC, et al. Survival of Bifidobacterium lactisHN019 and release of biogenic compounds in unfermented and fermented milk is affected by chilled storage at 4°C. Journal of Probiotics and Health. 2013; 4:114. DOI: 10.4172/2329-8901.1000114
Monagas M, Urpi-Sarda M, Sánchez-Patán F, Llorach R, Garrido I, Gómez-Cordovés C, et al. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food & Function. 2010; 1:233-253
Dharmaraj S. Marine Streptomycesas a novel source of bioactive substances. World Journal of Microbiology and Biotechnology. 2010; 26:2123-2139. DOI: 10.1139/cjm-2013-0785
Mitsuoka T. Development of functional foods. Bioscience of Microbiota, Food and Health. 2014; 33(3):117-128
Taniguchi M, Nakazawa H, Takeda O, Kaneko T, Hoshino K, Tanaka T. Production of a mixture of antimicrobial organic acids from lactose by co-culture of Bifidobacterium longumand Propionibacterium freudenreichii. Bioscience, Biotechnology, and Biochemistry. 1998; 62:1522-1527
Piard JC, Desmazeaud M. Inhibiting factors produced by lactic acid bacteria. 1. Oxygen metabolites and catabolism end-products. Le Lait. 1991; 71(5):525-541
Klaenhammer TR. Bacteriocins of lactic acid bacteria. Biochimie. 1988; 70:337-349
Marty-Teysset C, De La Torre F, Garel JR. Increased production of hydrogen peroxide by Lactobacillus delbrueckiisubsp. bulgaricus upon aeration: Involvement of an NADH oxidase in oxidative stress. Applied and Environmental Microbiology. 2000; 66:262-267
Shokryazdan P, Sieo CC, Kalavathy R, Liang JB, Alitheen NB, Jahromi MF, et al. Probiotic potential of Lactobacillusstrains with antimicrobial activity against some human pathogenic strains. BioMed Research International. 2014. DOI: 10.1155/2014/927268
Chen H, Hoover DG. Bacteriocins and their food applications. Comprehensive Reviews in Food Science and Food Safety. 2003; 2:82-100
Pascual LM, Daniele MB, Giordano W, Pajaro MC, Barberis IL. Purification and partial characterization of novel bacteriocin L23 produced by Lactobacillus fermentumL23. Current Microbiology. 2008; 56:397-402
Sharma A, Srivastava S. Anti-Candida activity of two-peptide bacteriocins, plantaricins (Pln E/F and J/K) and their mode of action. Fungal Biology. 2014; 118:264-275
Okkers DJ, Dicks LMT, Silvester M, Joubert JJ, Odendaal HJ. Characterization of pentocin TV35b, a bacteriocin-like peptide isolated from Lactobacillus pentosuswith a fungistatic effect on Candida albicans. Journal of Applied Microbiology. 1999; 87:726-734
Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends in Microbiology. 2001; 9:327-335
Douglas LJ. Candida biofilm and their role in infection. Trends in Microbiology. 2003; 11:30-36
Talarico TL, Casas IA, Chung TC, Dobrogosz WJ. Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrobial Agents and Chemotherapy. 1988; 32(12):1854-1858
Schütz H, Radler F. Anaerobic reduction of glycerol to propanediol-1.3 by Lactobacillus brevisand Lactobacillus buchneri. Systematic and Applied Microbiology. 1984; 5(2):169-178
Claisse O, Lonvaud-Funel A. Assimilation of glycerol by a strain of Lactobacillus collinoidesisolated from cider. Food Microbiology. 2000; 17(5):513-519
Magnusson J, Ström K, Roos S, Sjögren J, Schnürer J. Broad and complex antifungal activity among environmental isolates of lactic acid bacteria. FEMS Microbiology Letters. 2003; 219(1):129-135
Talarico TL, Dobrogosz WJ. Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri. Antimicrobial Agents and Chemotherapy. 1989; 33:674-679
Schaefer L, Auchtung TA, Hermans KE, Whitehead D, Borhan B, Britton RA. The antimicrobial compound reuterin (3-hydroxypropionaldehyde) induces oxidative stress via interaction with thiol groups. Microbiology. 2010; 156(6):1589-1599
Ganzle MG. Characterization of reutericyclin produced by Lactobacillus reuteriLTH2584. Applied and Environmental Microbiology. 2000; 66:4325-4333
Jay JM. Antimicrobial properties of diacetyl. Applied and Environmental Microbiology. 1982; 44(3):525-532
Chung TC, Axelsson L, Lindgren SE, Dobrogosz WJ. In vitro studies on reuterin synthesis by Lactobacillus reuteri. Microbial Ecology in Health and Diseases. 1989; 2:137-144
Corey RB. Crystal structure of diketopiperazine. Journal of the American Chemical Society. 1938; 60:1598-1604. DOI: 10.1021/ja01274a023
Martins MB, Carvalho I. Diketopiperazines: Biological activity and synthesis. Tetrahedron. 2007; 63:9923-9932. DOI: 10.1016/j.tet.2007.04.105
Nicholson B. NPI-2358 is a tubulin-depolymerizing agent: In-vitro evidence for activity as a tumor vascular-disrupting agent. Anti-Cancer Drugs. 2006; 17:25. DOI: 10.1097/01.cad.0000182745.01612.8a
Sinha S, Srivastava R, Clercq D, Erik, Singh RK. Synthesis and antiviral properties of arabino and ribonucleosides of 1,3-dideazaadenine, 4-nitro-1,3-dideazaadenine and diketopiperazine. Nucleosides, Nucleotides & Nucleic Acids. 2004; 23(12):1815-1824. DOI: 10.1081/NCN-200040614
Houston DR, Synstad B, Eijsink VGH, Stark MJR, Eggleston IM, van Aalten DMF. Structure-based exploration of cyclic dipeptide chitinase inhibitors. Journal of Medicinal Chemistry. 2004; 47(23):5713-5720. DOI: 10.1021/jm049940a
Kwon OS, Park SH, Yun B-S, Pyun YR, Kim C-J. Cyclo(dehydroala-L-Leu), an a-glucosidase inhibitor from Penicilliumsp. F70614. The Journal of Antibiotics. 2000; 53(9):954-958
Li H, Liu L, Zhang S, Cui W, Lv J. Identification of antifungal compounds produced by Lactobacillus caseiAST18. Current Microbiology. 2012; 65(2):156-161
Ström K, Sjögren J, Broberg A, Schnürer J. Lactobacillus plantarumMiLAB 393 produces the antifungal cyclic dipeptides cyclo (L-Phe-L-Pro) and cyclo (L-Phe-trans-4-OH-L-Pro) and 3-phenyllactic acid. Applied and Environmental Microbiology. 2002; 68(9):4322-4327
Niku-Paavola ML, Laitila A, Mattila-Sandholm T, Haikara A. New types of antimicrobial compounds produced by Lactobacillus plantarum. Journal of Applied Microbiology. 1999; 86(1):29-35
Li J, Wang W, Xu SX, Magarvey NA, McCormick JK. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in Staphylococci. Proceedings of the National Academy of Sciences. 2011; 108(8):3360-3365
Ryan LA, Zannini E, Dal Bello F, Pawlowska A, Koehler P, Arendt EK. Lactobacillus amylovorusDSM 19280 as a novel food-grade antifungal agent for bakery products. International Journal of Food Microbiology. 2011; 146(3):276-283
Yang EJ, Chang HC. Purification of a new antifungal compound produced by Lactobacillus plantarumAF1 isolated from Kimchi. International Journal of Food Microbiology. 2010; 139(1-2):56-63
Japan Patent JP2018-070463A. Anti-bacterial agent containing cyclic dipeptide against periodontal pathogens; 2018
Banni S. Conjugated linoleic acid metabolism. Current Opinion in Lipidology. 2002; 13(3):261-266
Sugano M, Tsujita A, Yamasaki M, Noguchi M, Yamada K. Conjugated linoleic acid modulates tissue levels of chemical mediators and immunoglobulins in rats. Lipids. 1998; 33(5):521-527
Mazidi M, Karimi E, Rezaie P, Ferns GA. Effects of conjugated linoleic acid supplementation on serum C-reactive protein: A systematic review and meta-analysis of randomized controlled trials. Cardiovascular Therapeutics. 2017; 35(6):e12275
Flemming HC, Wingender J. The biofilm matrix. Nature Reviews. Microbiology. 2010; 8:623-633
Allison DG. The biofilm matrix. Biofouling. 2003; 19:139-150
Wimpenny J. An overview of biofilms as functional communities. In: Allison D, Gilbert P, Lappin-Scott HM, Wilson M, editors. Society for General Microbiology Symposium. Community Structure and Co-operation in Biofilms, Vol. 59. Cambridge: Cambridge University Press; 2000
Sperandio V, Torres AG, Jarvis B, Nataro JP, Kaper JB. Bacteria–host communication: The language of hormones. Proceedings of the National Academy of Sciences. 2003; 100(15):8951-8956
Liévin-Le Moal V, Servin AL. Anti-infective activities of Lactobacillusstrains in the human intestinal microbiota: From probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clinical Microbiology Reviews. 2014; 27(2):167-199
Li J, Wang W, Xu SX, Magarvey NA, McCormick JK. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proceedings of the National Academy of Sciences. 2011; 108(8):3360-3365